Romidepsin is an antineoplastic agent classified as a histone deacetylase (HDAC) inhibitor. It is derived from a natural compound isolated from the bacterium *Chromobacterium violaceum*. Romidepsin is primarily used in the treatment of certain types of cancer, particularly T-cell lymphomas.
